Class waivers
Submitted by Anonymous (not verified) on 3 June 2025 - 13:35
Class waivers
EMA/PDCO summary report on the review of the list of granted Class Waivers 2 June 2025
Submitted by Anonymous (not verified) on 3 June 2025 - 13:34
EMA/PDCO summary report on the review of the list of granted Class Waivers 2 June 2025
Superseded - EMA/PDCO Summary Report on the review of the list of granted Class Waivers
Submitted by Anonymous (not verified) on 3 June 2025 - 13:31
Superseded - EMA/PDCO Summary Report on the review of the list of granted Class Waivers
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Submitted by Anonymous (not verified) on 3 June 2025 - 13:21
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 3 June 2025 - 10:42
Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised
Agenda - Workshop on the use of Bayesian statistics in clinical development
Submitted by Anonymous (not verified) on 3 June 2025 - 9:28
Agenda - Workshop on the use of Bayesian statistics in clinical development
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 2 June 2025 - 18:11
Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised
Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025
Submitted by Anonymous (not verified) on 2 June 2025 - 16:26
Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025
Faecal microbiota transplantation EU-IN Horizon Scanning Report
Submitted by Anonymous (not verified) on 2 June 2025 - 16:22
Faecal microbiota transplantation EU-IN Horizon Scanning Report
Agenda of the PRAC meeting 2-5 June 2025
Submitted by Anonymous (not verified) on 2 June 2025 - 16:18
Agenda of the PRAC meeting 2-5 June 2025